Pharmacos ink green manufacturing pact with EU academics
December 3, 2012Manufacturing and Production Bayer, EU, Pharmacos, Sanofi
A group of top pharma multinationals have set up a public-private partnership dedicated to the development of manufacturing sustainable pharmaceuticals …
Janssen eases HIV patent burden
December 3, 2012Sales and Marketing AIDS, Janssen, Prezista, darunavir
In a move which should appeal to public health campaigners, Janssen has declared that it will not enforce patents for …
Help CCGs help you, pharma told
November 30, 2012Medical Communications, Sales and Marketing CCGs, JSNA, NHS, pharma
Pharma companies have a big opportunity to take advantage of the changes in the structure of the NHS, according to …
Ranbaxy suspends atorvastatin manufacturing after recall
November 30, 2012Manufacturing and Production FDA, Ranbaxy, atorvastatin, recall
Ranbaxy Laboratories has called a halt to manufacturing its generic atorvastatin product until it can get to the bottom of …
New chief executive for Cipla
November 30, 2012Manufacturing and Production, Research and Development, Sales and Marketing Cipla, Subhanu Saxena
Indian pharma firm Cipla has announced the appointment of Novartis’ Subhanu Saxena as its chief executive. Saxena joins Cipla in …
NICE: ‘lot of work’ to do on VBP
November 30, 2012Medical Communications, Sales and Marketing Boysen, NHS, NICE, QALY, VBP
NICE is still working out what its role with the new NHS Commissioning Board will be, with other key issues …
Novartis R&D warning
November 29, 2012Research and Development, Sales and Marketing NHS, Novartis. R&D, trials
Novartis has hit out at what it sees as the high cost of UK clinical trials, warning that business will …
Eylea approval for wet AMD
November 29, 2012Sales and Marketing Bayer, Eylea, Lucentis, Novartis, avastin, wet AMD
Bayer HealthCare’s Eylea has been appoved in Europe for the treatment of neovascular age-related macular degeneration (wet AMD). The eye …
Genzyme appoints new GM for UK and Ireland
November 29, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brendan Martin, Genzyme
Genzyme has announced the appointment of Brendan Martin as general manager for UK and Ireland. Martin will be responsible for …
Survey: pharma losing $564 billion each year
November 28, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cap Gemini, Health Prize, pharma
Pharma companies are losing $564 billion each year – more than half the industry’s $956 billion revenue worldwide last year …
Another indication for Humira
November 28, 2012Sales and Marketing Abbott, Crohn's, EU, Humira
Abbott’s Humira has received its ninth indication in Europe with approval to treat youngsters suffering from the inflammatory bowel disease …
RSA welcomes new starter
November 28, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Huberts, rsa
Life Sciences Executive Search and Interim Management specialists RSA, has announced that Michael Huberts has joined the UK business as …
TranslateMedia listed in the Deloitte UK Fast 50 for the third year running
November 27, 2012Medical Communications
International translation and transcreation agency, TranslateMedia has been listed in the Deloitte UK Fast 50 for the third consecutive year, …
EMA’s five points on data release
November 27, 2012Medical Communications, Research and Development, Sales and Marketing EFPIA, EMA, Rasi, transparency
The European Medicines Agency has highlighted five areas that need to be ironed out before it begins publishing clinical trial …
‘Adopt NICE decisions’ committee told
November 27, 2012Sales and Marketing ABPI, Dorrell, NHS, NICE, Whitehead
ABPI chief executive Stephen Whitehead has again urged the NHS to adopt and use the drugs which NICE approves, and …
Targacept confirms Stephen Hill as president and chief executive
November 27, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Targacept, stephen hill
Clinical-stage biopharma firm Targacept has announced that Stephen Hill has been appointed as president and chief executive. Hill is expected …
Glass particles force recall of Ranbaxy Lipitor
November 27, 2012Manufacturing and Production, Sales and Marketing Daiichi Sankyo, Lipitor, Pfizer, Ranbaxy, recall
Ranbaxy Pharmaceuticals is recalling around 40 batches of its generic atorvastatin tablets after discovering that some of the product may …
UCB sells Indian production plant to Exemed
November 27, 2012Manufacturing and Production API, Exemed, UCB, vapi
UCB Pharma has signed a deal to sell its manufacturing facility in Vapi, India, to local firm Exemed Pharmaceuticals. The …
MPs pharma investigation in offing
November 26, 2012Sales and Marketing ABPI, Bad pharma, M&P, MP, NICE, trial data
A health select committee inquiry into pharma companies withholding clinical trial data is being considered, according to committee chair Stephen …
Summit appoints two non-executive directors
November 26, 2012Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Frank Armstrong, Jim Mellon, summit
UK drug discovery and development firm Summit has appointed Jim Mellon and Dr Frank Armstrong as non-executive directors. The additions …
Latest content
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care
